The effect of combination therapy of methylphenidate and Atomoxetine in the treatment of hyperactivity-disordered childre

Phase 3

• Conditions: Attention Deficit Hyperactivity Disorder.

• Registration Number: IRCT20190526043708N1
• Lead Sponsor: Mashhad University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 24

Inclusion Criteria

Patients with ADHD
aged 6-17 years
patients who are not treated concurrently with medicinal or non-drug therapy
IQ of more than 70

Exclusion Criteria

Family dissatisfaction with continued treatment
Incidence of side effects

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Parents' ADHD/RS Score. Timepoint: 0 and 4 weeks later. Method of measurement: Questionnaire.